Journals / MN Kardiyoloji / 2017 / Cilt: 24 - Sayı: 1

Massive Pulmonary Thromboembolism and Succesful Thrombolytic Treatment in a Patient with Rhemumatoid Arthritis

Romatoid Artriti Olan Hastada Masif Pulmoner Tromboemboli ve Başarılı Trombolitik Tedavisi

Pages
24–26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We reported a case that massive pulmonary thromboembolism in a patient with rheumatoid arthritis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary thromboembolism is a disorder that causes high mortality rate in the acute phase.
📊
Key Findings & Data:However addition thrombolytic agent to anti-coagulant therapy in patients with moderate risk pulmonary embolism is not clear.
💡
Conclusion & Impact:We reported a case that massive pulmonary thromboembolism in a patient with rheumatoid arthritis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary thromboembolism is a disorder that causes high mortality rate in the acute phase. Thrombolytic therapy is a life saving treat-ment in patients with high risk pulmonary thromboembolism without contraindications. However addition thrombolytic agent to anti-coagulant therapy in patients with moderate risk pulmonary embolism is not clear. In recent studies, addition thrombolytic agent to an-ticoagulant therapy in patients with moderate risk pulmonary thromboembolism had found safely in patients with low bleeding risk pro-file. There are many situations that predispose to pulmonary embolism. Immobilization, obesity, post-operative period, the presence of cancer, thrombophilia and use of oral contraceptive are some of them. Some autoimmune diseases may increase the risk of venous thromboembolism. Also rheumatoid arthritis have been reported to increase the risk of venous thromboembolism. We reported a case that massive pulmonary thromboembolism in a patient with rheumatoid arthritis.

Özet

Pulmoner tromboemboli akut dönemde yüksek mortaliteye neden olan bir hastalıktır. Yüksek riskli pulmoner tromboemboli varlığında kontrendikasyon yoksa trombolitik tedavi hayat kurtarıcıdır. Fakat orta riskli pulmoner tromboemboli hastalarında antikoagülan tedavi-ye trombolitik ajan eklenmesi net değildir. Son zamanlarda yapılan çalışmalarda kanama risk profili düşük olan hastalarda antikoagü-lan tedaviye düşük doz trombolitik tedavinin güvenle eklenebileceği belirtilmektedir. Pulmoner tromboemboliye yatkınlık oluşturan bir çok klinik durum vardır. İmmobilizasyon, obezite, operasyon sonrası dönem, kanser varlığı, trombofili, oral kontraseptif kullanımı gibi du-rumlar bunlardan bazılarıdır. Otoimmün hastalıkların bir kısmı venöz tromboembolizm riskini arttırabilir. Romatoid artritin de venöz tromboembolizm riskini arttırdığı bildirilmiştir. Biz romatoid artritli bir hastada gelişen masif pulmoner emboli vakasını sunduk.

🔖

Cite This Article

KALAYCI, B., KORKMAZ, A., KALAYCI, S., DUMAN, İ. (2017). Massive Pulmonary Thromboembolism and Succesful Thrombolytic Treatment in a Patient with Rhemumatoid Arthritis. MN Kardiyoloji, Cilt: 24 - Sayı: 1, 24–26. https://ajindex.com/articles/297215

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary em-bolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology. Eur Heart J 2008;29(18):2276-315
  2. Johannesdottir SA, Schmidt M, Horváth-Puhó E, Sorensen HT. Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 2012;10(5):815-21
  3. Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL. Noncardiac vascular disease in rheumatoid arthritis: in-crease in venous thromboembolic events. Arthritis Rheum 2012;64(1):53-61
  4. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. “MOPETT” Investigators. Moderate Pulmonary Embolism Treated With Thrombolysis. Am J Cardiol 2013;15;111(2): 273-7.